{{chembox
| Verifiedfields = changed
| verifiedrevid = 477163087
| ImageFile = Melanotan II.svg
| ImageSize = 275px
| IUPACName = 
| Name = Melanotan II
| pronounce ={{IPAc-en|audio=Pronunciation-melanotan.ogg|m|ɛ|ˈ|l|æ|n|oʊ-|t|æ|n}}
| OtherNames = 
<br/>Ac-Nle-cyclo[Asp-His-<small>D</small>-Phe-Arg-Trp-Lys]-NH<sub>2</sub>
<br/>Ac-Nle-c[Asp-His-<small>D</small>-Phe-Arg-Trp-Lys]-NH<sub>2</sub>
<br/>Ac-cyclo[Nle<sup>4</sup>, Asp<sup>5</sup>,<small>D</small>-Phe<sup>7</sup>, Lys<sup>10</sup>]α-MSH<sub>4–10</sub>-NH<sub>2</sub>
<br/>''N''-Acetyl-<small>L</small>-norleucyl-<small>L</small>-α-aspartyl-<small>L</small>-histidyl-<small>D</small>-phenylalanyl-<small>L</small>-arginyl-<small>L</small>-tryptophyl-<small>L</small>-lysinamide (2→7)-lactam
<br/>PT-14

| Section1 = {{Chembox Identifiers
| CASNo_Ref = {{cascite|changed|??}}
| CASNo = 121062-08-6
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 430239
| PubChem = 92432 
| IUPHAR_ligand = 1323
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 83450
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C50H69N15O9/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56)/t35-,36-,37-,38+,39-,40-,41-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JDKLPDJLXHXHNV-MFVUMRCOSA-N
| SMILES =
| MeSHName = melanotan-II
  }}

| Section2 = {{Chembox Properties
| Formula = C<sub>50</sub>H<sub>69</sub>N<sub>15</sub>O<sub>9</sub> 
| MolarMass = 1024.180 
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
  }}

| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}
[[Image:Thumb-Melanotan-II.gif|thumb]])]]

'''美拉諾坦 II'''（Melanotan II）<ref name=Adis>{{cite web|title=Melanotan II|url=http://adisinsight.springer.com/drugs/800010143|publisher=AdisInsight|accessdate=6 April 2017|language=en}}</ref>是一種人工[[多肽合成|合成]]的{{tsl|en|α-melanocyte-stimulating hormone|α-黑素細胞刺激激素}}（α-MSH）{{tsl|en|analog (chemistry)|類似物  (化學)|類似物}}，α-MSH屬於[[肽类激素|肽類激素]]。 

本品在開發期間的目標是作為治療[[女性性功能障碍|女性性功能障礙]]和[[勃起功能障碍|勃起功能障礙]]的候選藥物，但在2003年停止開發。截至2018年，尚無含有美拉諾坦 II 的產品上市，有關此藥物的{{tsl|en|drug development|藥物開發|}}也都已經停止<ref name=Adis/>。 在網路上可以發現許多標榜含有美拉諾坦 II 的無牌商品在市場上流通，被認為是有效的{{tsl|en|sunless tanning|仿曬劑}}，但有成色不均勻、長新的[[痣|痣]]或原有的[[痣|痣]]變黑或變大等副作用，因此醫療機構不建議使用<ref>{{Cite journal|title=Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review|author=|url=http://onlinelibrary.wiley.com/doi/10.1111/ijd.13585/abstract|last=Habbema|first=Louis|last2=Halk|first2=Anne Berthe|date=2017-10-01|journal=International Journal of Dermatology|issue=10|doi=10.1111/ijd.13585|others=|year=|volume=56|page=|pages=975–980|issn=1365-4632|pmid=|last3=Neumann|first3=Martino|last4=Bergman|first4=Wilma}}</ref><ref>{{Cite journal|title=The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review|author=|url=http://onlinelibrary.wiley.com/doi/10.1111/hsc.12326/abstract|last=Brennan|first=Rebekah|last2=Wells|first2=John S.G.|date=2017-09-01|journal=Health & Social Care in the Community|issue=5|doi=10.1111/hsc.12326|others=|year=|volume=25|page=|pages=1459–1531|issn=1365-2524|pmid=|last3=Van Hout|first3=Marie Claire}}</ref>。 

==作用機轉 ==
美拉諾坦 II 為{{tsl|en|melanocortin receptor|黑皮質素受體|}}的非選擇性[[激动剂|激動劑]]，可活化{{tsl|en|melanocortin 1 receptor||MC<sub>1</sub>}}、{{tsl|en|melanocortin 3 receptor||MC<sub>3</sub>}}、{{tsl|en|melanocortin 4 receptor||MC<sub>4</sub>}}、{{tsl|en|melanocortin 5 receptor||MC<sub>5</sub>}}等受體<ref name="Wikberg2001">{{cite journal|last1=Wikberg|first1=Jarl ES|title=Melanocortin receptors: new opportunities in drug discovery|journal=Expert Opinion on Therapeutic Patents|volume=11|issue=1|year=2001|pages=61–76|issn=1354-3776|doi=10.1517/13543776.11.1.61}}</ref>。 

美拉諾坦 II 能夠促進[[黑素細胞|黑素細胞]]的生成，可能是藉由活化{{tsl|en|melanocortin 1 receptor||MC<sub>1</sub>}}受體所致，而其在性方面的效果被認為與其激活{{tsl|en|melanocortin 4 receptor||MC<sub>4</sub>}}受體的能力有關（{{tsl|en|melanocortin 3 receptor||MC<sub>3</sub>}} 受體可能也與其有關）。<ref name="NorrisLopez2010">{{cite book|author1=David O. Norris|author2=Kristin H. Lopez|title=Hormones and Reproduction of Vertebrates|url=https://books.google.com/books?id=HKv3mC5Eb34C&pg=RA4-PA152|date=25 November 2010|publisher=Academic Press|isbn=978-0-08-095809-5|pages=4–}}</ref><ref name=":0">{{Cite journal|title=Melanocortin Receptors, Melanotropic Peptides and Penile Erection|url=http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0266&volume=7&issue=11&spage=1111|last=Hunter Wessells|last2=Wessells|first2=Hunter|date=2007-05-31|journal=Current Topics in Medicinal Chemistry|issue=11|doi=10.2174/1568026610707011111|volume=7|pages=1111–1119|language=en|last3=Hruby|first3=Victor J.|last4=Balse-Srinivasan|first4=Preeti|last5=King|first5=Stephen H.}}</ref>

美拉諾坦 II 的[[不良反應_(醫學)|不良反應]]包括[[潮紅|潮紅]]、[[恶心|噁心]]、[[呕吐|嘔吐]]、{{tsl|en|stretching|伸展}}、[[哈欠|哈欠]]，和[[食欲不振|食欲不振]]（食慾不振與MC<sub>4</sub>的活化相關）<ref name="PlantZeleznik2014">{{cite book|author1=Tony M. Plant|author2=Anthony J. Zeleznik|title=Knobil and Neill's Physiology of Reproduction: Two-Volume Set|url=https://books.google.com/books?id=I1ACBAAAQBAJ&pg=PA2230|date=15 November 2014|publisher=Academic Press|isbn=978-0-12-397769-4|pages=2230–}}</ref><ref name="WeinKavoussi2011">{{cite book|author1=Alan J. Wein|author2=Louis R. Kavoussi|author3=Andrew C. Novick |author4=Alan W. Partin |author5=Craig A. Peters |title=Campbell-Walsh Urology|url=https://books.google.com/books?id=W1aeyJD46kIC&pg=PA743|date=28 September 2011|publisher=Elsevier Health Sciences|isbn=1-4557-2298-7|pages=743–}}</ref>。

==歷史==
在1960年代初的研究發現，給予大鼠α-MSH會引起其性反應。到1980年代在許多實驗室中仍繼續做這樣的實驗，亞利桑那大學的科學家開始試圖開發α-MSH或其類似物作為潛在的仿曬劑，並合成和測試了幾個類似物，包括{{tsl|en|melanotan-I|美拉諾坦 I}} 和美拉諾坦 II<ref name="King2007rev">{{vcite2 journal|vauthors=King SH, Mayorov AV, Balse-Srinivasan P, Hruby VJ, Vanderah TW, Wessells H|title=Melanocortin receptors, melanotropic peptides and penile erection|journal=Curr Top Med Chem|volume=7|issue=11|pages=1098–1106|year=2007|pmid=17584130|pmc=2694735|doi=10.2174/1568026610707011111}}</ref><ref name=Hadley2005>{{cite journal|last1=Hadley|first1=ME|title=Discovery that a melanocortin regulates sexual functions in male and female humans.|journal=Peptides|date=October 2005|volume=26|issue=10|pages=1687-9|doi=10.1016/j.peptides.2005.01.023|pmid=15996790}}</ref>。  

在該藥物研發的起步階段，其中一位科學家決定拿自己做實驗，將兩倍預期劑量的美拉諾坦 II 注射到自己身上，結果造成他連續勃起8小時，並伴有噁心和嘔吐<ref>{{Cite journal|title=Melanocortin Receptors, Melanotropic Peptides and Penile Erection|url=http://www.eurekaselect.com/78408/article|last=Mayorov|first=Hunter Wessells,    Todd W. Vanderah,    Victor J. Hruby,    Preeti Balse-Srinivasan,    Stephen H. King and     Alexander V.|date=2007-05-31|journal=Current Topics in Medicinal Chemistry|issue=11|volume=7|language=en}}</ref>。 

於是亞利桑那大學運營的{{tsl|en|technology transfer|技術轉讓}}公司 Competitive Technologies 便將{{tsl|en|melanotan-I|美拉諾坦 I}}以仿曬劑候選物的形式技轉給一家名為Epitan的澳大利亞[[初创企业|新創公司]]（2006年更名為Clinuvel）<ref name=HadleyDorr2006>{{cite journal|last1=Hadley|first1=ME|last2=Dorr|first2=RT|title=Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.|journal=Peptides|date=April 2006|volume=27|issue=4|pages=921-30|doi=10.1016/j.peptides.2005.01.029|pmid=16412534}}</ref><ref>{{cite news|title=Epitan changes name to Clinuvel, announces new clinical program|url=http://www.labonline.com.au/content/life-scientist/news/epitan-changes-name-to-clinuvel-announces-new-clinical-program-161764385|work=LabOnline|date=27 February 2006|language=en}}</ref>。而美拉諾坦 II 則以性功能障礙藥物被技轉給帕拉丁科技（Palatin Technologies）<ref name="Hadley2005" />。帕拉丁技術公司在2000年結束了美拉諾坦 II 的開發，重新開發另一種專利新藥，即{{tsl|en|bremelanotide|布美諾肽}}（可能為美拉諾坦 II的代謝物），與美拉諾坦 II 的不同處在於布美諾肽以一個羧基取代美拉諾坦的酰胺基<ref name=":0" /><ref>{{Cite web|url=https://www.prnewswire.com/news-releases/palatin-technologies-refutes-competitive-technologies-contention-of-material-breach-58006787.html|title=Palatin Technologies Refutes Competitive Technologies Contention of Material Breach|accessdate=2018-01-24|last=Inc.|first=Palatin Technologies,|work=www.prnewswire.com|language=en|archive-url=https://web.archive.org/web/20171201084843/https://www.prnewswire.com/news-releases/palatin-technologies-refutes-competitive-technologies-contention-of-material-breach-58006787.html|archive-date=2017-12-01|dead-url=yes}}</ref>。於是 Competitive Technologies 控告帕拉丁科技違約，並聲稱其具有對{{tsl|en|bremelanotide|布美諾肽}}的權利<ref name="Litigation">{{cite news|url=http://www.prnewswire.com/news-releases/palatin-technologies-refutes-competitive-technologies-contention-of-material-breach-58006787.html|title=Press Release: Palatin Technologies Refutes Competitive Technologies Contention of Material Breach|date=September 12, 2007|work=Palatin Technologies via PR Newswire|language=en}}</ref>。雙方於2008年和解，帕拉丁科技保有{{tsl|en|bremelanotide|布美諾肽}}的權利，並支付80萬美元給 Competitive Technologies ，而 Competitive Technologies 則繼續保有美拉諾坦 II 的權利<ref>{{cite news|title=Press Release: Palatin Technologies Announces Litigation Settlement With Competitive Technologies|url=http://www.prnewswire.com/news-releases/palatin-technologies-announces-litigation-settlement-with-competitive-technologies-57107302.html|work=Palatin Technologies via PR Newswire|date=January 22, 2008|language=en}}</ref>。

== 社會和文化 ==
許多產品在市場上銷售，在健身房和美容院中被稱為“美拉諾坦 ”或“美拉諾坦 -1”或“美拉諾坦 -2”。<ref>{{Cite web|url=http://wcbstv.com/topstories/tanorexia.melanotan.self.2.1013828.html |publisher={{tsl|en|WCBS-TV||WCBS-TV}}, [[CBS_(電視網)|CBS]] |date=2009-05-20 |accessdate=2009-07-23 |title=Believe It Or Not 'Tanorexia' A Very Real Problem |deadurl=yes |archiveurl=https://web.archive.org/web/20090521151930/http://wcbstv.com/topstories/tanorexia.melanotan.self.2.1013828.html |archivedate=May 21, 2009 }}</ref><ref>{{Cite web|url=http://www.cosmopolitan.com.au/fool_gold.htm |date=2009-06-14 |title=Fools Gold |accessdate=2009-07-25 |publisher=[[柯夢波丹|Cosmopolitan]] (Australia) |deadurl=yes |archiveurl=https://web.archive.org/web/20090912150202/http://cosmopolitan.com.au/fool_gold.htm |archivedate=2009-09-12 |df= }}</ref> <ref name="Wired-01-09">{{Cite news|url=https://www.wired.com/wiredscience/2009/01/tan/ |title=Suntan Drug Greenlighted for Trials |accessdate=2009-04-11 |publisher=[[连线|Wired]] |date=2009-01-29 |first=Alexis |last=Madrigal |archiveurl=https://web.archive.org/web/20090505032522/http://www.wired.com/wiredscience/2009/01/tan/ |archivedate=5 May 2009 |deadurl=no |df= }}</ref>   

這些產品在任何司法轄區都是不合法的，並且是危險的，從2007年開始，各郡的衛生機構開始發出警告，禁止繼續使用。<ref name="HeraldSun">{{Cite web|url=http://www.heraldsun.com.au/news/tanning-drug-a-health-risk/story-e6frf7jo-1225792923321|title=Tanning drug a health risk|accessdate=2009-10-31|publisher={{tsl|en|Herald Sun||Herald Sun}}|date=2009-10-31}}</ref><ref>{{cite journal
|author1=Ewan A Langan |author2=Z. Nie |author3=Lesley E Rhodes |title=Melanotropic peptides: More than just "Barbie drugs" and "sun tan jabs?" |journal=British Journal of Dermatology |volume=163
|issue=3 |pages=451–5 |date=June 2010 |pmid=20545686 |doi=10.1111/j.1365-2133.2010.09891.x }}</ref><ref>{{cite journal |author1=Ewan A Langan |author2=Denise Ramlogan |author3=Lynne A Jamieson |author4=Lesley E Rhodes |title=Change in moles linked to use of unlicensed "sun tan jab" |journal=BMJ |volume=338 |pages=b277 |date=January 2009 |doi=10.1136/bmj.b277 | pmid = 19174439 }}</ref><ref>{{cite news|url=http://news.bbc.co.uk/2/hi/health/7895366.stm |title=Risky tan jab warnings 'ignored' |accessdate=2009-03-04 |publisher=[[英国广播公司|BBC]] |date=2009-02-18 |archiveurl=https://web.archive.org/web/20090221213602/http://news.bbc.co.uk/2/hi/health/7895366.stm |archivedate=21 February 2009 |deadurl=no |df= }}</ref><ref>{{Cite web|url=http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelID=13865|title=Warning against the product Melanotan|accessdate=2008-08-11|publisher={{tsl|en|Danish Medicines Agency||Danish Medicines Agency}}|year=2008}}</ref><ref>{{Cite web|url=http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON031009 |title="Tan jab" is an unlicensed medicine and may not be safe |accessdate=2008-11-17 |publisher={{tsl|en|Medicines and Healthcare products Regulatory Agency||MHRA}} |year=2008 |deadurl=yes |archiveurl=https://web.archive.org/web/20081218195906/http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON031009 |archivedate=2008-12-18 |df= }}</ref><ref>{{Cite web|url=http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm152426.htm|title= US Lab Research Inc Warning letter|accessdate=2009-07-23|publisher=U.S. [[美国食品药品监督管理局|Food and Drug Administration]]|date=2009-01-29| archiveurl= https://web.archive.org/web/20090710061631/http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm152426.htm| archivedate= 10 July 2009 <!--DASHBot-->| deadurl= no}}</ref><ref name="IMB">{{Cite web|url=http://www.imb.ie/EN/Safety--Quality/Advisory-Warning--Recall-Notices/Human-Medicines/Melanotan-Powder-for-Injection-.aspx|title=Melanotan Powder for Injection|accessdate=2009-02-02|publisher=<!-- 頁面不存在 -->[[Irish_Medicines_Board|Irish Medicines Board]]|year=2009|work=Notice Information: – Warning – 27 February 2009}}</ref><ref>{{Cite web|url=http://www.slk.no/templates/InterPage____65110.aspx |title=Legemiddelverket advarer mot bruk av Melanotan |accessdate=2009-03-11 |publisher=Norwegian Medicines Agency |date=2007-12-13 |archiveurl=https://web.archive.org/web/20090417045006/http://www.slk.no/templates/InterPage____65110.aspx |archivedate=17 April 2009 |deadurl=yes |df= }}</ref><ref name="NoMA">{{Cite web|url=http://www.slk.no/templates/InterPage____80434.aspx |title=Melanotan – farlig og ulovlig brunfarge |accessdate=2009-03-11 |publisher={{tsl|en|Norwegian Medicines Agency||Norwegian Medicines Agency}} |date=2009-01-23 |archiveurl=https://web.archive.org/web/20090417045159/http://www.slk.no/templates/InterPage____80434.aspx |archivedate=17 April 2009 |deadurl=yes |df= }}</ref>

== 參考 ==
* {{tsl|en|Methoxsalen|甲氧沙林}}

== 資料來源 ==
{{Reflist|2}}


{{Melanocortin receptor modulators}}

<!-- 沒有連結 -->[[Category:Melanocortin_receptor_agonists|Category:Melanocortin receptor agonists]]
[[Category:肽|Category:肽]]
<!-- 沒有連結 -->[[Category:Abandoned_drugs|Category:Abandoned drugs]]